|
🐬
|
High‐risk groups of patients with Stage II colon carcinoma
S. Merkel,
A. Wein,
K. Günther,
T. Papadopoulos,
W. Hohenberger,
P. Hermanek
|
7 |
2001 |
7
🐬
|
|
🐜
|
NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma—Very good response predominantly in patients with intestinal type tumors
16 auth.
C. Schulz,
F. Kullmann,
V. Kunzmann,
M. Fuchs,
M. Geissler,
U. Vehling‐Kaiser,
H. Stauder,
A. Wein,
S. Al-Batran,
T. Kubin,
...
C. Schäfer,
S. Stintzing,
C. Giessen,
D. Modest,
K. Ridwelski,
V. Heinemann
|
6 |
2015 |
6
🐜
|
|
🦁
|
Neoadjuvant Treatment with Weekly High-Dose 5-Fluorouracil as 24-Hour Infusion, Folinic Acid and Oxaliplatin in Patients with Primary Resectable Liver Metastases of Colorectal Cancer
13 auth.
A. Wein,
C. Riedel,
W. Brückl,
S. Merkel,
R. Ott,
B. Hanke,
U. Baum,
F. Fuchs,
K. Günther,
T. Reck,
...
T. Papadopoulos,
E. G. Hahn,
Werner Hohenberger
|
6 |
2003 |
6
🦁
|
|
🐜
|
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer.
18 auth.
S. Boeck,
T. Hoehler,
G. Seipelt,
R. Mahlberg,
A. Wein,
A. Hochhaus,
H. Boeck,
B. Schmid,
E. Kettner,
M. Stauch,
...
Florian Lordick,
Y. Ko,
Michael Geissler,
K. Schoppmeyer,
G. Kojouharoff,
A. Golf,
Sophie Neugebauer,
V. Heinemann
|
6 |
2008 |
6
🐜
|
|
🦁
|
Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid.
14 auth.
A. Wein,
C. Riedel,
F. Köckerling,
P. Martus,
Ulrich Baum,
W. Brueckl,
T. Reck,
R. Ott,
J. Hänsler,
T. Bernatik,
...
Dirk Becker,
Thomas Schneider,
Werner Hohenberger,
E. G. Hahn
|
6 |
2001 |
6
🦁
|
|
🐢
|
Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy.
13 auth.
W. Brueckl,
Christian Moesch,
T. Brabletz,
Corinna Koebnick,
C. Riedel,
Andreas Jung,
S. Merkel,
S. Schaber,
F. Boxberger,
Thomas Kirchner,
...
Werner Hohenberger,
E. G. Hahn,
A. Wein
|
6 |
2003 |
6
🐢
|
|
🐢
|
CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA).
10 auth.
B. Hanke,
C. Riedel,
S. Lampert,
K. Happich,
P. Martus,
H. Parsch,
...
B. Himmler,
Werner Hohenberger,
E. G. Hahn,
A. Wein
|
5 |
2001 |
5
🐢
|
|
🐜
|
Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials
11 auth.
A. Wagner,
P. Buechner-Steudel,
M. Moehler,
H. Schmalenberg,
R. Behrens,
J. Fahlke,
...
A. Wein,
S. Behl,
O. Kuss,
G. Kleber,
W. Fleig
|
5 |
2009 |
5
🐜
|
|
🐬
|
Primary signet-ring cell carcinoma of the colorectum
B. Bittorf,
S. Merkel,
K. Matzel,
A. Wein,
A. Dimmler,
W. Hohenberger
|
5 |
2004 |
5
🐬
|
